UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): October 18, 2016
Acadia Healthcare Company, Inc.
(Exact Name of Registrant as Specified in Its Charter)
| Delaware | 001-35331 | 45-2492228 | ||
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
| 6100 Tower Circle, Suite 1000 Franklin, Tennessee |
37067 | |
| (Address of Principal Executive Offices) | (Zip Code) |
(615) 861-6000
(Registrant’s Telephone Number, including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 2.02. | Results of Operations and Financial Condition. |
On October 18, 2016, Acadia Healthcare Company, Inc., a Delaware corporation (the “Company”), issued a press release announcing, among other matters, its preliminary summary financial results of operations for the third quarter ended September 30, 2016. The press release is furnished herewith as Exhibit 99 hereto and is incorporated herein by reference.
| Item 7.01. | Regulation FD Disclosure. |
On October 18, 2016, the Company issued a press release announcing its preliminary summary financial results of operations for the third quarter ended September 30, 2016. The press release also announced the signing of a definitive agreement for the sale of certain facilities located in the United Kingdom in fulfillment of the Company’s previously announced undertakings to the Competition and Markets Authority (“CMA”) in the U.K. to address the CMA’s concerns about competition in the provision of behavioral healthcare services in certain markets related to the Company’s acquisition of Priory Group. The sale is subject to the approval of the CMA. The press release is furnished herewith as Exhibit 99 hereto and is incorporated herein by reference.
| Item 9.01. | Financial Statements and Exhibits. |
| (d) | Exhibits. |
| Exhibit |
Description | |
| 99 | Press Release, dated October 18, 2016 | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ACADIA HEALTHCARE COMPANY, INC. | ||||||||
| Date: October 18, 2016 | By: | /s/ Christopher L. Howard | ||||||
| Christopher L. Howard Executive Vice President, Secretary and General Counsel | ||||||||
EXHIBIT INDEX
| Exhibit |
Description | |
| 99 | Press Release, dated October 18, 2016 | |